Bond & Devick Financial Network Inc. Sells 204 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

by · The Cerbat Gem

Bond & Devick Financial Network Inc. trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 2.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,890 shares of the healthcare conglomerate’s stock after selling 204 shares during the quarter. UnitedHealth Group comprises approximately 2.2% of Bond & Devick Financial Network Inc.’s investment portfolio, making the stock its 11th biggest position. Bond & Devick Financial Network Inc.’s holdings in UnitedHealth Group were worth $5,198,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the stock. Weil Company Inc. acquired a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $289,000. Delta Financial Advisors LLC grew its stake in UnitedHealth Group by 4.3% during the third quarter. Delta Financial Advisors LLC now owns 3,783 shares of the healthcare conglomerate’s stock worth $2,212,000 after buying an additional 157 shares in the last quarter. Addison Advisors LLC boosted its position in shares of UnitedHealth Group by 12.9% during the 3rd quarter. Addison Advisors LLC now owns 480 shares of the healthcare conglomerate’s stock worth $281,000 after acquiring an additional 55 shares in the last quarter. GDS Wealth Management boosted its holdings in shares of UnitedHealth Group by 8.9% in the 3rd quarter. GDS Wealth Management now owns 21,539 shares of the healthcare conglomerate’s stock valued at $12,593,000 after purchasing an additional 1,761 shares in the last quarter. Finally, Catalytic Wealth RIA LLC lifted its position in shares of UnitedHealth Group by 8.8% during the 3rd quarter. Catalytic Wealth RIA LLC now owns 9,959 shares of the healthcare conglomerate’s stock worth $5,823,000 after buying an additional 807 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $617.50 on Monday. The firm has a market capitalization of $568.27 billion, a price-to-earnings ratio of 40.12, a PEG ratio of 1.81 and a beta of 0.58. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $619.80. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock’s 50 day moving average is $581.93 and its 200-day moving average is $545.85.

UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same period last year, the firm earned $6.56 EPS. The business’s quarterly revenue was up 9.2% compared to the same quarter last year. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.36%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s payout ratio is currently 54.72%.

Analysts Set New Price Targets

A number of research analysts have recently commented on UNH shares. Bank of America dropped their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Stephens dropped their price target on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and upped their target price for the stock from $481.00 to $647.00 in a report on Wednesday, July 17th. Robert W. Baird upped their price objective on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research note on Wednesday, July 17th. Finally, Wells Fargo & Company boosted their target price on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $615.53.

Check Out Our Latest Stock Report on UNH

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles